Wellness designed for you.
Sanguina was founded to help people like us, and people like you. Our team is personally connected to health and wellness and passionate about empowering people to take control of your health and wellness at your fingertips. Our technologies were developed within the biomedical engineering and pediatrics departments at the Georgia Institute of Technology, Emory University, the Centers for Disease Control and Children's Healthcare of Atlanta. Our multidisciplinary team has developed AnemoCheck from the ground up. We have published scientific findings and initial clinical assessments. We are transparent and let our science do the talking. From all of us at Sanguina, we’re pleased to meet you.
Meet the Sanguina founders who are passionate about health and wellness at your fingertips.
Erika A. Tyburski
Chief Executive Officer
Erika has had iron deficiency anemia her whole life. Having always had her anemia screened at a hospital, she wanted to change the script and empower herself and others to track anemia and other health and wellness conditions at home. She was motivated to start Sanguina right after graduating with her bachelor’s degree in Biomedical Engineering in 2012. She worked alongside Rob Mannino to invent the AnemoCheck technologies at the Georgia Institute of Technology. Since then, she has garnered experience in clinical testing, regulatory efforts, design control processes and quality management systems for the company. Everyday, she works to make life easier for people who want to manage their health and wellness.
Wilbur A. Lam,
Chief Medical Officer
Wilbur is a bioengineer and clinical pediatric hematologist/oncologist who is currently an Assistant Professor of Biomedical Engineering at Emory University and the Georgia Institute of Technology and the Department of Pediatrics, Division of Hematology/Oncology at Emory University School of Medicine. Dr. Lam leads an interdisciplinary laboratory based at Georgia Tech and Emory dedicated to developing novel, inexpensive diagnostics for hematologic and childhood diseases. Wilbur serves as Chief Medical Officer of Sanguina and continues to supervise technical development of AnemoCheck.
Chief Technology Officer
Rob earned his PhD in biomedical engineering at the Georgia Institute of Technology and Emory University in 2018. Rob suffers from beta thalassemia major, a genetic blood disorder that causes him to be severely anemic and requires that he receive regular blood transfusions. His experience living with this disease motivates him to develop diagnostic technologies for anemia that can improve quality of life. Rob has extensive experience in computational analysis and leads development of our AnemoCheck Mobile.
Chief Financial Officer
Rene is an entrepreneur with over 18 years of startup experience in numerous companies. During this time, he has played senior roles in finance, marketing, scaling operations, and business development. Rene has been instrumental in establishing and scaling early-stage companies in various industries. Rene received both his undergraduate degree and MBA at MIT. He has joined Sanguina as CFO focused on the financial model, funding and business development.
Tom S. Stribling
Tom has over twenty-five years of experience in the health care industry, and companies he led have consistently reached successful and profitable liquidity through sale to larger corporations. Prior to Sanguina, he started three other companies and joined three companies in turn-around situations. All of these experiences were at the President and/or CEO level.
Chief Scientific Officer
Andrew is currently Professor of Chemistry and Founding Dean of the Fowler School of Engineering at Chapman University in Orange, CA and holds seven issued U.S. patents. Andrew has extensive experience in redox chemistry and dye-mediated electron transfer systems such as those utilized in AnemoCheck. He currently serves as Chief Scientific Officer of Sanguina.
Thank you to our partners!
Want to also take part in Sanguina’s development?
Send us a message regarding partnership opportunities.